Country, language and currency
- Social bookmarks:
- Testimonials
-
Read more »
Our billing is certified by:
-
- Biomerica Launches New Patented Test to Identify Individuals at Risk of ... - MarketWatch (press release)
- Biomerica Launches New Patented Test to Identify Individuals at Risk of
- Challenges and Solutions to Immunosuppressant Therapy - Drug Discovery & Development
- Challenges and Solutions to Immunosuppressant TherapyDrug Discovery & DevelopmentThere are a number of immunosuppressive drugs on the market including tacrolimus, sirolimus, cyclosporine, mycophenolate mofetil, and azathioprine
- Abbott Drug Gets Positive Review in Ulcerative Colitis - dailyRx
- Abbott Drug Gets Positive Review in Ulcerative ColitisdailyRxHumira will be indicated for the treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA),
- Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 - MarketWatch (press release)
- Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019MarketWatch (press release)
- EMA advisory backs Humira for UC and expanded use of Byetta - The Pharma Letter
- EMA advisory backs Humira for UC and expanded use of ByettaThe Pharma LetterThe drug will be indicated for the treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA),
